Glaxo attracts big book for €2.5bn after five year absence from euros
GlaxoSmithKline has returned to the euro bond market after a five year absence with a big double tranche transaction. The UK pharmaceuticals company priced €1.5bn of five year and €1bn of 10 year bonds on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
